1-5 of 5
Catherine Joyce Arago Cheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and Non-Hodgkin Lymphoma in Pediatric Patients

George E. Hucks, Jr., Barbara Savoldo, Gianpietro Dotti, Catherine Joyce Arago Cheng, Caroline Babinec, Kimberly A. Kasow, Michael Winstead, Arpita Patel, Cammie Presler, Natalie S Grover, J. Kaitlin Morrison, Anne W. Beaven, Marcie L. Riches, Thomas C. Shea, Jonathan S. Serody
Journal: Blood
Blood (2021) 138 (Supplement 1): 2829.
DOI: https://doi.org/10.1182/blood-2021-153968
Published: 2021
Journal Articles

CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma

Natalie S Grover, Anastasia Ivanova, Dominic T. Moore, Catherine Joyce Arago Cheng, Caroline Babinec, John West, Tammy Cavallo, J. Kaitlin Morrison, Faith Brianne Buchanan, Edith Bowers, Christopher Dittus, Anne W. Beaven, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo
Journal: Blood
Blood (2021) 138 (Supplement 1): 742.
DOI: https://doi.org/10.1182/blood-2021-148102
Published: 2021
Journal Articles

Safety and Antitumor Effects of CD19-Specific Autologous Chimeric Antigen Receptor-Modified T (CAR-T) Cells Expressing the Inducible Caspase 9 Safety Switch (iC9-CAR19 T Cells) in Adult Acute Lymphoblastic Leukemia (ALL)

Matthew C Foster, MD, Philip A. Roehrs, MD, George E Hucks, MD, Natalie S Grover, MD, Paul M. Armistead, MD PhD, Katarzyna Jamieson, MD, Faith Brianne Buchanan, PA, J. Kaitlin C Morrison, PhD, Spencer Laing, BA, Catherine Joyce Arago Cheng, BS, Jonathan S. Serody, MD, Gianpietro Dotti, MD, Barbara Savoldo, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
DOI: https://doi.org/10.1182/blood-2020-139051
Published: 2020
Journal Articles

Retrospective Cohort Study Analyzing the Safety and Efficacy of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Timothy J Voorhees, MD, Natalie S Grover, MD, Anne Beaven, MD, Steven I Park, MD, J. Kaitlin Morrison, PhD, Catherine Joyce Arago Cheng, BS, Spencer Laing, BA, Gianpietro Dotti, MD, Barbara Savoldo, MD PhD, Jonathan S Serody, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3233.
DOI: https://doi.org/10.1182/blood-2019-122846
Published: 2019
Journal Articles

Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin

Natalie S Grover, MD, Steven I Park, MD, Anastasia Ivanova, PhD, Paul Eldridge, PhD, Kathryn McKay, MS, MT (ASCP), Catherine Joyce Arago Cheng, BS, Spencer Laing, BA, Deborah Covington, RN, BSN, John West, PhD, S. Elizabeth Sharf, RN, BSN, J. Kaitlin Morrison, PhD, Shaw Scott, Erin Crecelius, MA, Desirae Shelley, Maurice Alexander, PharmD, Faith Brianne Buchanan, PA, Emily Herrick Kassam, NP, Megan McElfresh, PA-C, Alicia R Pinto, NP, Angela Denise Spruill, ANP, Ashley Zanter, ANP, Kimberly Wehner, FNP, Christopher Dittus, DO, Thomas C. Shea, MD, Gianpietro Dotti, MD, Jonathan S Serody, MD, Anne Beaven, MD, Barbara Savoldo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 681.
DOI: https://doi.org/10.1182/blood-2018-99-113534
Published: 2018